Michael L. Maitland

Host Defense Mechanisms Triggered by Microbial Lipoproteins Through Toll-Like Receptors

Hans D. Brightbill, Daniel H. Libraty, Stephan R. Krutzik et al. · Science · 1999 · 1.7K citations

Life Sciences, Immunology, Microbiology +17

CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis

Julian D. Gillmore, Ed Gane, Jörg Täubel et al. · New England Journal of Medicine · 2021 · 1.6K citations · Full text

Life Sciences, Genetics, Molecular Biology +14

Initial Assessment, Surveillance, and Management of Blood Pressure in Patients Receiving Vascular Endothelial Growth Factor Signaling Pathway Inhibitors

Michael L. Maitland, George L. Bakris, Henry R. Black et al. · JNCI Journal of the National Cancer Institute · 2010 · 407 citations · Full text

Medicine, Oncology, Pharmacology +17

Carboplatin and Paclitaxel in Combination With Either Vorinostat or Placebo for First-Line Therapy of Advanced Non–Small-Cell Lung Cancer

Suresh S. Ramalingam, Michael L. Maitland, Paul Frankel et al. · Journal of Clinical Oncology · 2009 · 270 citations

Medicine, Oncology, Pharmacology +16

Design of Phase II Cancer Trials Using a Continuous Endpoint of Change in Tumor Size: Application to a Study of Sorafenib and Erlotinib in Non Small-Cell Lung Cancer

Theodore Karrison, Michael L. Maitland, Walter M. Stadler et al. · JNCI Journal of the National Cancer Institute · 2007 · 176 citations · Full text

Medicine, Oncology, Pharmacology +16